Investigational new drugPeptide
Compound 61432
Formula Pending
Molecular Mass
N/A
CAS Registry
AUTO-061432
Risk Class
MODERATE
Last Audit
Feb 6, 2108
Research Abstract
Peptide candidate engineered for endocrine support initiatives with automated dossier coverage.
Compound 61432 is a peptide asset inside peptide innovation track initiatives, optimized for endocrine support and performance longevity.
The dossier currently sits in investigational new drug with a moderate risk rating, meaning it is requires layered oversight with metabolic labs.
Supply records cite CAS AUTO-061432 with updates logged 2108-02-06.
Acquisition Protocol
Authorized research personnel may request deployment of this compound for laboratory analysis.
Primary Vectors
Endocrine supportPerformance longevity
Nomenclature
CX-61432Peptide Program 61432
Reference Material
- [1] Anubis Compound Registry • CAS AUTO-061432
- [2] Operations Pulse • Peptide innovation track
- [3] Risk Governance Ledger • MODERATE clearance for COMPOUND-61432